NOV 02, 2016 8:12 PM PDT

Drug-Eluting Stents Are Just As Effective As Open-Heart Surgery

WRITTEN BY: Kara Marker
A large study of nearly two thousand patients with left main coronary artery disease (LMCAD) has confirmed to scientists that the treatment of this disease is just as effective with a drug-eluting stent as it is with coronary artery bypass graft (CABG) surgery.
Image credit: The Coronary Channel from Medtronic
In the past, scientists have studied the potential for drug-eluting stents as a less-invasive alternative to CABG surgery, but now lead author Gregg W. Stone, MD, of the recent New England Journal of Medicine study says that “stents have gotten better, and so has cardiac bypass surgery. That required us to take a fresh look at the relative safety and effectiveness of the two approaches."

Stone and his team, cardiologists and cardiac surgeons from 126 centers in 17 countries, randomized 1,905 patients with LMCAD and low or intermediate coronary artery disease in other coronary arteries to receive either a drug-eluting stent that releases an antiproliferative agent called everolimus or CABG surgery, and they followed the patients for at least two years to observe their health outcomes. The large, international study is called Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL).

The results showed around fifteen percent of patients from both groups had a heart attack, stroke, or died within three years, Stone reported. "In other words, stents were equally effective as bypass surgery."

Drug-eluting stents are installed in the diseased artery through a catheter, making it a much less-invasive option than CABG. The stents release antiproliferative medications to prevent the artery from becoming blocked again after the procedure. Stone and colleagues believe that this option is especially appropriate for patients with LMCAD without extensive blockages in other coronary arteries.

The research team also focused on health outcomes of patients from the two randomized groups within the first 30 days following the procedure, the time period in which the most serious complications are most likely to occur. The patients who received drug-eluting stents showed a clear advantage: they had a three percent lower incidence of death, stroke, heart attack, or revascularization, and fewer stent patients had major bleeding, infections, kidney failure, or severe abnormal heart rhythms.

Stone and his team have yet to study patients with LMCAD and extensive blockages in the rest of the coronary arteries; all of the participants from this study had only mild blockages in their other coronary arteries, so they still recommend coronary artery bypass graft surgery for patients with more serious blockages.

"While bypass is still considered a more durable repair, patients and doctors may prefer a percutaneous treatment approach, which is associated with better upfront results, fewer complications, and quicker recovery,” Stone confirmed.

LMCAD occurs when the primary artery supplying oxygen-rich blood to most of the heart muscle is blocked by athersclerotic plaque, and about two-thirds of LMCAD cases are also accompanied by mild to moderate disease in the rest of the coronary arteries. For years, the standard treatment for all cases of LMCAD has been CABG surgery.

“Many patients with left main coronary artery disease who prefer a minimally invasive approach can now rest assured that a stent is as effective as bypass surgery for at least 3 years, and is initially safer, with fewer complications from the procedure," Stone said.
 


Source: Columbia University Medical Center, JACC Cardiovascular Interventions, Circulation
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JAN 19, 2021
Cardiology
Risk of Atrial Fibrillation Raised by Daily Alcoholic Drink
JAN 19, 2021
Risk of Atrial Fibrillation Raised by Daily Alcoholic Drink
Some studies have suggested that moderate alcohol intake is linked to a lower risk of death from heart disease. But that ...
MAR 15, 2021
Cardiology
'Silent' Heart Attacks Linked to Significant Increase in Stroke Risk
MAR 15, 2021
'Silent' Heart Attacks Linked to Significant Increase in Stroke Risk
Silent heart attacks can happen, in which blood flow to the heart is blocked, and heart tissue may be damaged, but they ...
MAY 17, 2021
Cardiology
Healthier Hearts are Linked to Better Cognitive Function
MAY 17, 2021
Healthier Hearts are Linked to Better Cognitive Function
Researchers have found an association between healthier hearts and better cognitive abilities, like faster reaction time ...
JUL 15, 2021
Drug Discovery & Development
The genomics of high blood pressure - a road to the future of treatment
JUL 15, 2021
The genomics of high blood pressure - a road to the future of treatment
The human heart begins to beat in utero in the early weeks of development and continues throughout life. In an average l ...
JUL 16, 2021
Technology
Echocardiogram May Help Predict COVID-19 Patients at Risk for Heart Complications
JUL 16, 2021
Echocardiogram May Help Predict COVID-19 Patients at Risk for Heart Complications
Researchers learned early on in the pandemic that COVID-19 infections caused a range of complications throughout the bod ...
JUL 16, 2021
Cardiology
Therapeutic Exosome Spray May One Day Aid Heart Attack Recovery
JUL 16, 2021
Therapeutic Exosome Spray May One Day Aid Heart Attack Recovery
When the flow of blood to the heart is blocked, heart cells don't get enough oxygen and begin to die; this is a heart at ...
Loading Comments...